AGM/EGMApr 26, 2026, 05:27 AM
ETON 2026 Annual Meeting Set for June 9; Director Elections
AI Summary
Eton Pharmaceuticals, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 9, 2026, at 10:00 a.m. CDT. Key proposals include the election of Jenn Adams and Charles J. Casamento as Class II directors and the ratification of Grant Thornton LLP as the independent registered public accounting firm for fiscal year 2026. The record date for stockholders entitled to vote is April 10, 2026, with 27,359,791 shares outstanding.
Key Highlights
- Eton Pharmaceuticals will hold its 2026 Annual Meeting of Stockholders virtually on June 9, 2026.
- Stockholders will vote to elect Jenn Adams and Charles J. Casamento as Class II directors.
- Stockholders will also ratify Grant Thornton LLP as the independent auditor for fiscal year 2026.
- The record date for voting eligibility is April 10, 2026.
- There are 27,359,791 shares of common stock outstanding as of April 10, 2026.
- Non-employee director compensation for 2025 ranged from $267,027 to $318,047, including option awards.
- The board consists of five members, with Jenn Adams and Charles J. Casamento nominated for a three-year term.
Price Impact
More from ETON